HIV Cure Program of American Gene Technologies Adds University of Maryland School of Medicine’s Institute of Human Virology as New Study Site to Support the Development of a Cell and Gene Therapy for HIV
02 juil. 2019 16h33 HE
|
American Gene Technologies
ROCKVILLE, Md., July 02, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT), a leading gene and cell therapy company based in Rockville, MD, selected the Institute of Human Virology (IHV) at...
Incysus Therapeutics Appoints Rozanna Yaing As Senior Vice President, Quality And Regulatory Affairs
02 juil. 2019 08h00 HE
|
Incysus Therapeutics, Inc.
NEW YORK, July 02, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Lung Cancer Therapeutics Market to reach US$ 48,725.9 Mn by 2026, exhibiting a CAGR of 13.0% | Exclusive Report by Fortune Business Insights
27 juin 2019 08h38 HE
|
Fortune Business Insights
Pune, June 27, 2019 (GLOBE NEWSWIRE) -- Targeted segment is forecast to emerge dominant among various therapies in the Lung Cancer Therapeutics Market, finds Fortune Business Insights in a new...
Todos Medical to Sponsor the Investacure ‘Cure Coin Awards Reception’ for Alzheimer’s and CTE Research at AAIC 2019 in Los Angeles
27 juin 2019 08h00 HE
|
Todos Medical Ltd.
REHOVOT, Israel, June 27, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Fluidigm Highlights New Advancements in Deep Cellular Profiling from Circulation to Tissue at CYTO 2019
20 juin 2019 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Introduces Three Imaging Mass Cytometry Panel Kits and Advanced CyTOF Software to Accelerate Immuno-Oncology Research
19 juin 2019 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Incysus Therapeutics Announces Publication of U.S. Patent for Drug Resistant Immunotherapy (DRI) Technology
19 juin 2019 08h00 HE
|
Incysus Therapeutics, Inc.
US Patent and Trademark Office Issues U.S. Patent Covering Drug Resistant Immunotherapy (DRI) TechnologyClaims Provide Initial Protection for Incysus’ Novel DRI PlatformIncysus Controls Exclusive...
Todos Medical CEO Presented Corporate Update And Roadmap at The LD Micro Conference
17 juin 2019 08h30 HE
|
Todos Medical Ltd.
REHOVOT, Israel, June 17, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
INmune Bio Inc. Featured in Exclusive NetworkNewsWire Broadcast
11 juin 2019 08h30 HE
|
INmune Bio, Inc.
NEW YORK, June 11, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune...
Todos Medical Receives Approval from Israeli Ministry of Health (AMAR) to Market and Sell its Breast Cancer Screens in Israel
23 mai 2019 08h00 HE
|
Todos Medical Ltd.
REHOVOT, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...